272 related articles for article (PubMed ID: 28212680)
21. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies.
Sandweiss AJ; Brandt VL; Zoghbi HY
Lancet Neurol; 2020 Aug; 19(8):689-698. PubMed ID: 32702338
[TBL] [Abstract][Full Text] [Related]
22. MeCP2 Dysfunction in Rett Syndrome and Neuropsychiatric Disorders.
Chin EWM; Goh ELK
Methods Mol Biol; 2019; 2011():573-591. PubMed ID: 31273722
[TBL] [Abstract][Full Text] [Related]
23. The molecular pathology of Rett syndrome: synopsis and update.
Akbarian S; Jiang Y; Laforet G
Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
[TBL] [Abstract][Full Text] [Related]
24. Abnormal N-glycosylation pattern for brain nucleotide pyrophosphatase-5 (NPP-5) in Mecp2-mutant murine models of Rett syndrome.
Cortelazzo A; De Felice C; Guerranti R; Signorini C; Leoncini S; Pecorelli A; Scalabrì F; Madonna M; Filosa S; Della Giovampaola C; Capone A; Durand T; Mirasole C; Zolla L; Valacchi G; Ciccoli L; Guy J; D'Esposito M; Hayek J
Neurosci Res; 2016 Apr; 105():28-34. PubMed ID: 26476268
[TBL] [Abstract][Full Text] [Related]
25. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
[TBL] [Abstract][Full Text] [Related]
26. The relationship of Rett syndrome and MECP2 disorders to autism.
Neul JL
Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
28. Deleterious mutations in exon 1 of MECP2 in Rett syndrome.
Quenard A; Yilmaz S; Fontaine H; Bienvenu T; Moncla A; des Portes V; Rivier F; Mathieu M; Raux G; Jonveaux P; Philippe C
Eur J Med Genet; 2006; 49(4):313-22. PubMed ID: 16829352
[TBL] [Abstract][Full Text] [Related]
29. MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex.
Kyle SM; Saha PK; Brown HM; Chan LC; Justice MJ
Hum Mol Genet; 2016 Jul; 25(14):3029-3041. PubMed ID: 27288453
[TBL] [Abstract][Full Text] [Related]
30. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model.
Vermudez SAD; Gogliotti RG; Arthur B; Buch A; Morales C; Moxley Y; Rajpal H; Conn PJ; Niswender CM
Genes Brain Behav; 2022 Jan; 21(1):e12752. PubMed ID: 34002468
[TBL] [Abstract][Full Text] [Related]
31. Homozygous c.1160C>T (P38L) in the MECP2 gene in a female Rett syndrome patient.
Bhanushali AA; Mandsaurwala A; Das BR
J Clin Neurosci; 2016 Mar; 25():127-9. PubMed ID: 26755454
[TBL] [Abstract][Full Text] [Related]
32. Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.
Zachariah RM; Rastegar M
Neural Plast; 2012; 2012():415825. PubMed ID: 22474603
[TBL] [Abstract][Full Text] [Related]
33. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.
Sinnett SE; Gray SJ
Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692
[TBL] [Abstract][Full Text] [Related]
34. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
35. The role of MeCP2 in CNS development and function.
Na ES; Monteggia LM
Horm Behav; 2011 Mar; 59(3):364-8. PubMed ID: 20515694
[TBL] [Abstract][Full Text] [Related]
36. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
37. P152R Mutation Within MeCP2 Can Cause Loss of DNA-Binding Selectivity.
Franklin D
Interdiscip Sci; 2019 Mar; 11(1):10-20. PubMed ID: 30673959
[TBL] [Abstract][Full Text] [Related]
38. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features and MECP2 mutations in children with Rett syndrome].
Zhao PW; He XL; Lin J; Wu GF; Yue X; Bi B; Hu JS; Liu ZS
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):393-6. PubMed ID: 24750837
[TBL] [Abstract][Full Text] [Related]
40. Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2.
Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Jorge-Torres OC; Esteller M; Abian O; Velazquez-Campoy A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
